Medically reviewed by David Ozeri, MD Complement 3 glomerulopathy (C3G) is considered a very rare disease. With C3G, patients have issues with their immune system that cause kidney damage and symptoms ...

Medically reviewed by Erika Prouty, PharmD Key Takeaways There are two types of complement 3 glomerulopathy: dense deposit ...

A new study by the National Cancer Research Centre (CNIO) has identified several sets of genes related to the predisposition ...

The US Food and Drug Administration (FDA) has granted Fast Track Designation to Complement Therapeutics’ CTx001, the ...

New research shows yoga helps individuals in rehab for opioid addiction recover more quickly and with decreased cravings, ...

Full-year 2025 preliminary1 U.S. net product revenues of $689 millionSYFOVRE® (pegcetacoplan injection) total injection demand grew 17% ...

This knowledge would help identify individuals who could benefit from early detection programmes, which are essential for a ...

Potential to Be the First Targeted Fast-Acting Therapy for GBS, Setting a New Standard of Care BLA Submission with U.S./European Data from ...

From football fields to military training grounds, head injuries are leaving lasting marks on the brain in ways we're only ...

As we head into the 2026, let's take a look at biotech licensing deals and M&As that were inked in December 2025.

OpenAI just released a report about healthcare drawn from anonymized chatbot conversations. The title could double as one of ...

A research team provides an overview of how engineered probiotics—genetically modified beneficial microbes—are being transformed into living medicines capable of sensing disease, delivering therapies, ...